Detalhe da pesquisa
1.
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 20(1): 110-119, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522967
2.
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Oncologist
; 24(3): 385-393, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30606884
3.
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.
J Neurooncol
; 145(1): 115-123, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31556015
4.
Correction to: Efficacy of initial temozolomide for highrisk low grade gliomas in a phase II AINO (Italian Association for NeuroOncology) study: a posthoc analysis within molecular subgroups of WHO 2016.
J Neurooncol
; 145(3): 593, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31691059
5.
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
J Neurooncol
; 136(1): 221-222, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29124650
6.
Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma.
J Neurooncol
; 128(2): 333-9, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27029617
7.
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
J Neurooncol
; 128(1): 157-162, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26943851
8.
Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
J Neurooncol
; 125(2): 359-67, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26423801
9.
Benefit from anthracyclines in relation to biological profiles in early breast cancer.
Breast Cancer Res Treat
; 144(2): 307-18, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24381054
10.
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.
Breast Cancer Res Treat
; 125(3): 775-84, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21132360
11.
Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer.
Oncology
; 78(3-4): 274-81, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20530973
12.
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.
Cancer Chemother Pharmacol
; 79(5): 863-871, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341957
13.
Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Cancer Chemother Pharmacol
; 77(1): 115-20, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26659583
14.
Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing.
Int J Biol Markers
; 31(4): e461-e465, 2016 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27516001
15.
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study.
Oncol Lett
; 11(1): 831-836, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26870292
16.
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.
Neuro Oncol
; 18(3): 401-7, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26354929
17.
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer.
Eur J Cancer
; 51(14): 1874-81, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26206258
18.
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study.
Tumori
; 100(6): e309-13, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25688518
19.
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?
Neurooncol Pract
; 1(4): 166-171, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26034628
20.
Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors.
Heart
; 99(9): 634-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23349345